Evolus Stock (NASDAQ:EOLS)
Previous Close
$5.77
52W Range
$5.71 - $17.82
50D Avg
$9.12
200D Avg
$11.57
Market Cap
$413.99M
Avg Vol (3M)
$1.39M
Beta
1.12
Div Yield
-
EOLS Company Profile
Evolus, Inc., a performance beauty company, provides medical aesthetic products for physicians and their patients in the United States. It offers Jeuveau, a proprietary 900 kilodalton purified botulinum toxin type A formulation for the temporary improvement in the appearance of moderate to severe glabellar lines in adults. The company was incorporated in 2012 and is headquartered in Newport Beach, California.